Promab Biotechnologies is a leading provider of cutting-edge technologies in the field of medicine. With expertise in CAR-T NK development, mRNA-LNP development, and antibody engineering, they offer a range of services that have the potential to revolutionize cancer care and advance therapeutic applications.
With a track record of generating thousands of monoclonal antibodies, filing numerous patents, and successfully completing hundreds of CAR-T projects, Promab Biotechnologies is at the forefront of innovation in the industry. Their validated platform and commitment to pushing the boundaries of medicine make them a trusted partner for researchers and pharmaceutical companies alike.
Generated from the website